Literature DB >> 23706563

Reconditioning of an injured lung graft with intrabronchial surfactant instillation in an ex vivo lung perfusion system followed by transplantation.

Ilhan Inci1, Sven Hillinger, Stephan Arni, Tevfik Kaplan, Demet Inci, Walter Weder.   

Abstract

BACKGROUND: We tested whether an injured lung graft from category-3 donation after cardiac death donor could be reconditioned with an ex vivo lung perfusion (EVLP) system by intrabronchial diluted surfactant lavage before transplantation.
METHODS: In a pig model, cardiac arrest was induced by deconnecting from the ventilator. Left lung injury was done by intrabronchial instillation of 1 mL/kg pepsin + HCl. After retrieval, the heart-lung block was stored at 4°C for 2 h. In the treated group, transplantation was performed after reconditioning with intrabronchial diluted surfactant lavage in EVLP system.
RESULTS: During EVLP, surfactant group showed better oxygenation and lower pulmonary vascular resistance. After transplantation, better oxygenation, lower mean pulmonary artery pressure, and lower lung edema were observed in surfactant group. Lower blood IL-1 beta and IL-6 cytokine levels were measured in the surfactant group. In bronchoalveolar lavage, the percentage of neutrophils, IL-1 beta and IL-6 cytokine levels, amount of protein, and neutrophil infiltration in the lung tissue at the end of the experiment were significantly lower in the surfactant group.
CONCLUSIONS: Our data demonstrate the feasibility of reconditioning and transplantation of an acutely damaged lung graft due to aspiration from a category-3 DCD donor. Implementation of an EVLP system is an efficacious tool to recondition and assess a questionable graft before transplantation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aspiration; Donation after cardiac death donor; Ex vivo lung perfusion; Lung transplantation; Porcine; Surfactant

Mesh:

Substances:

Year:  2013        PMID: 23706563     DOI: 10.1016/j.jss.2013.04.043

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

Review 1.  Organ preservation: from the past to the future.

Authors:  Lei Jing; Leeann Yao; Michael Zhao; Li-Ping Peng; Mingyao Liu
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

Review 2.  Donors after cardiocirculatory death and lung transplantation.

Authors:  Ilhan Inci
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 3.  Ex Vivo Lung Perfusion: Current Achievements and Future Directions.

Authors:  Nikhil K Prasad; Chetan Pasrija; Tara Talaie; Alexander S Krupnick; Yunge Zhao; Christine L Lau
Journal:  Transplantation       Date:  2021-05-01       Impact factor: 4.939

Review 4.  The porcine innate immune system: an update.

Authors:  K H Mair; C Sedlak; T Käser; A Pasternak; B Levast; W Gerner; A Saalmüller; A Summerfield; V Gerdts; H L Wilson; F Meurens
Journal:  Dev Comp Immunol       Date:  2014-04-04       Impact factor: 3.636

Review 5.  Ex vivo lung perfusion.

Authors:  Tatsuaki Watanabe; Marcelo Cypel; Shaf Keshavjee
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

6.  Functional, Metabolic and Morphologic Results of Ex Vivo Donor Lung Perfusion with a Perfluorocarbon-Based Oxygen Carrier Nanoemulsion in a Large Animal Transplantation Model.

Authors:  Ilhan Inci; Stephan Arni; Ilker Iskender; Necati Citak; Josep Monné Rodriguez; Miriam Weisskopf; Isabelle Opitz; Walter Weder; Thomas Frauenfelder; Marie Pierre Krafft; Donat R Spahn
Journal:  Cells       Date:  2020-11-18       Impact factor: 6.600

7.  Endothelin receptor antagonist improves donor lung function in an ex vivo perfusion system.

Authors:  K Walweel; K Skeggs; A C Boon; L E See Hoe; M Bouquet; N G Obonyo; S E Pedersen; S D Diab; M R Passmore; K Hyslop; E S Wood; J Reid; S M Colombo; N J Bartnikowski; M A Wells; D Black; L P Pimenta; A K Stevenson; K Bisht; L Marshall; D A Prabhu; L James; D G Platts; P S Macdonald; D C McGiffin; J Y Suen; J F Fraser
Journal:  J Biomed Sci       Date:  2020-10-02       Impact factor: 8.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.